Publication
Use of Etonogestrel Implant Beyond Approved Duration – A Case Report
dc.contributor.author | Castro Carvalho, C | |
dc.contributor.author | Silveira Reis, I | |
dc.contributor.author | Machado, AI | |
dc.date.accessioned | 2022-07-29T14:55:15Z | |
dc.date.available | 2022-07-29T14:55:15Z | |
dc.date.issued | 2022 | |
dc.description.abstract | The contraceptive implant is the most effective method of reversible contraception. Observational and trial data indicate that this method remains effective beyond the initially approved duration of use. We report a case of etonogestrel serum levels above the supposed threshold value for ovulation suppression nine years after implant insertion. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Acta Obstet Ginecol Port 2022;16(2):163-165 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/4174 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Federação das Sociedades Portuguesas de Obstetrícia e Ginecologia | pt_PT |
dc.subject | Etonogestrel implant | pt_PT |
dc.subject | Contraceptive effectiveness | pt_PT |
dc.subject | Nexplanon® | pt_PT |
dc.subject | Implanon NXT® | pt_PT |
dc.subject | Family planning | pt_PT |
dc.subject | MAC GIN | pt_PT |
dc.title | Use of Etonogestrel Implant Beyond Approved Duration – A Case Report | pt_PT |
dc.title.alternative | Uso do Implante de Etonogestrel Além da Duração Aprovada – Um Caso Clínico | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 165 | pt_PT |
oaire.citation.issue | 2 | pt_PT |
oaire.citation.startPage | 163 | pt_PT |
oaire.citation.volume | 16 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |